Glucosyl sphingosine is a lipid of Sphingolipids (SP) class. Glucosyl sphingosine is associated with abnormalities such as Sphingolipidoses, Globoid cell leukodystrophy, Sandhoff Disease, Tay-Sachs Disease and Fabry Disease. The involved functions are known as Apoptosis, Acetylation, Infiltration, kinase activity and energy pathways. Glucosyl sphingosine often locates in Lysosomal and Protoplasm. The associated genes with Glucosyl sphingosine are MAPT gene, GALC gene, HEXA gene, PICK1 gene and ELF3 gene. The related lipids are lysoganglioside G(M2), Ganglioside GA2, Lysophosphatidylcholines and globotriaosyl lysosphingolipid.
To understand associated biological information of Glucosyl sphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucosyl sphingosine is suspected in Globoid cell leukodystrophy, Sphingolipidoses, Sandhoff Disease, Tay-Sachs Disease, Fabry Disease and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with Glucosyl sphingosine
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Multiple Myeloma | D009101 | 13 associated lipids |
| Leukodystrophy, Globoid Cell | D007965 | 6 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Gaucher Disease | D005776 | 13 associated lipids |
| Parkinson Disease | D010300 | 53 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Smith NJ et al. | Reduced cerebral vascularization in experimental neuronopathic Gaucher disease. | 2018 | J. Pathol. | pmid:28981147 |
| Lukas J et al. | Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease. | 2017 | Int J Mol Sci | pmid:29053611 |
| Kang L et al. | Successful newborn screening for Gaucher disease using fluorometric assay in China. | 2017 | J. Hum. Genet. | pmid:28356566 |
| Taguchi YV et al. | Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease. | 2017 | J. Neurosci. | pmid:28847804 |
| Franco M et al. | Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease. | 2017 | Am. J. Hematol. | pmid:28621801 |
| Murugesan V et al. | Glucosylsphingosine is a key biomarker of Gaucher disease. | 2016 | Am. J. Hematol. | pmid:27441734 |
| Dai M et al. | Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease. | 2016 | PLoS ONE | pmid:27598339 |
| Gramlich PA et al. | A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment. | 2016 | J. Biotechnol. | pmid:26795355 |
| Dasgupta N et al. | Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. | 2015 | Hum. Mol. Genet. | pmid:26420838 |
| Sun Y et al. | Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology. | 2015 | PLoS ONE | pmid:25822147 |
| Burrow TA et al. | CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. | 2015 | Mol. Genet. Metab. | pmid:25219293 |
| Fuller M et al. | Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. | 2015 | Clin. Chim. Acta | pmid:26232157 |
| Mirzaian M et al. | Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. | 2015 | Blood Cells Mol. Dis. | pmid:25842368 |
| Aflaki E et al. | Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs. | 2014 | Sci Transl Med | pmid:24920659 |
| Gaspar P et al. | Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. | 2014 | J. Lipid Res. | pmid:24212238 |
| Angka L et al. | Glucopsychosine increases cytosolic calcium to induce calpain-mediated apoptosis of acute myeloid leukemia cells. | 2014 | Cancer Lett. | pmid:24631520 |
| Welford RW et al. | Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. | 2014 | PLoS ONE | pmid:25479233 |
| Sardi SP et al. | Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23297226 |
| Sun Y et al. | Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease. | 2013 | PLoS ONE | pmid:23520473 |
| Pavlova EV et al. | B cell lymphoma and myeloma in murine Gaucher's disease. | 2013 | J. Pathol. | pmid:23775597 |
| Rolfs A et al. | Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. | 2013 | PLoS ONE | pmid:24278166 |
| Cabrera-Salazar MA et al. | Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease. | 2012 | PLoS ONE | pmid:22912851 |
| Sun Y et al. | Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. | 2012 | J. Biol. Chem. | pmid:22167193 |
| Zhang CK et al. | Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. | 2012 | Am. J. Hematol. | pmid:22388998 |
| Li YT et al. | Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples. | 2011 | Neurochem. Res. | pmid:21136152 |
| Xu YH et al. | Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. | 2011 | Mol. Genet. Metab. | pmid:21257328 |
| Dekker N et al. | Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. | 2011 | Blood | pmid:21868580 |
| Auray-Blais C et al. | How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? | 2010 | Clin. Chim. Acta | pmid:20716442 |
| Sun Y et al. | Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. | 2010 | Hum. Mol. Genet. | pmid:20047948 |
| Imokawa G | A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. | 2009 | J. Dermatol. Sci. | pmid:19443184 |
| Mogi C et al. | Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. | 2005 | J. Pharmacol. Sci. | pmid:16210776 |
| Deguchi H et al. | Sphingolipids as bioactive regulators of thrombin generation. | 2004 | J. Biol. Chem. | pmid:14722105 |
| Okamoto R et al. | Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. | 2003 | J. Lipid Res. | pmid:12518027 |
| Lloyd-Evans E et al. | Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. | 2003 | Biochem. J. | pmid:12917012 |
| Tayebi N et al. | Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? | 2003 | Mol. Genet. Metab. | pmid:12809640 |
| Ishibashi M et al. | Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. | 2003 | Lab. Invest. | pmid:12649340 |
| Park JK et al. | Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. | 2003 | Pediatr. Res. | pmid:12595585 |
| Bodennec J et al. | Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride. | 2003 | J. Lipid Res. | pmid:12730305 |
| Schueler UH et al. | Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. | 2003 | Neurobiol. Dis. | pmid:14678774 |
| Lloyd-Evans E et al. | Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. | 2003 | J. Biol. Chem. | pmid:12709427 |
| Orvisky E et al. | Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. | 2002 | Mol. Genet. Metab. | pmid:12208131 |
| Jatana M et al. | Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. | 2002 | Neurosci. Lett. | pmid:12231442 |
| Sillence DJ et al. | Glucosylceramide modulates membrane traffic along the endocytic pathway. | 2002 | J. Lipid Res. | pmid:12401882 |
| Sprong H et al. | Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. | 2001 | J. Cell Biol. | pmid:11673476 |
| Sueyoshi N et al. | Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations. | 2001 | J. Lipid Res. | pmid:11483620 |
| Bischoff A et al. | Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. | 2001 | Br. J. Pharmacol. | pmid:11309265 |
| Kanazawa T et al. | Inhibition of cytokinesis by a lipid metabolite, psychosine. | 2000 | J. Cell Biol. | pmid:10811833 |
| Bischoff A et al. | Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. | 2000 | Br. J. Pharmacol. | pmid:10952677 |
| Bischoff A et al. | Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. | 2000 | Br. J. Pharmacol. | pmid:10952678 |
| Orvisky E et al. | Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. | 2000 | Pediatr. Res. | pmid:10926300 |
| Zehavi U | Synthesis of potentially caged sphingolipids, possible precursors of cellular modulators and second messengers. | 1997 | Chem. Phys. Lipids | pmid:9450322 |
| Yamaguchi Y et al. | The synthetic pathway for glucosylsphingosine in cultured fibroblasts. | 1994 | J. Biochem. | pmid:7852294 |
| Meivar-Levy I et al. | Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. | 1994 | Biochem. J. | pmid:7980395 |
| Sasagasako N et al. | Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity. | 1994 | J. Biochem. | pmid:8188616 |
| Atsumi S et al. | Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. | 1993 | Arch. Biochem. Biophys. | pmid:8323295 |
| Nozawa M et al. | Novel procedure for measuring psychosine derivatives by an HPLC method. | 1992 | J. Neurochem. | pmid:1629732 |
| Gopalan V et al. | Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases. | 1989 | Biochem. J. | pmid:2508630 |
| Igisu H et al. | Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. | 1988 | Lipids | pmid:2840545 |
| Legler G and Bieberich E | Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives. | 1988 | Arch. Biochem. Biophys. | pmid:2963589 |
| Hara A and Taketomi T | Chemical properties and stereoisomerism of heterogeneous long chain bases in lysosphingolipids by positive ion fast atom bombardment mass spectrometry and carbon-13 NMR spectroscopy. | 1986 | J. Biochem. | pmid:3782058 |
| Nilsson O et al. | Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants. | 1985 | Clin. Genet. | pmid:3924448 |
| Gatt S et al. | Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease. | 1982 | Prog. Clin. Biol. Res. | pmid:6812076 |
| Suzuki K | Glucosylceramide and related compounds in normal tissues and in Gaucher disease. | 1982 | Prog. Clin. Biol. Res. | pmid:7122635 |
| pmid: |